Literature DB >> 11227930

Hyperplastic polyps of the colorectum-innocent or guilty?

J R Jass1.   

Abstract

Hyperplastic polyps have traditionally been regarded as nonneoplastic polyps lacking malignant potential. The demonstration of genetic alterations within these lesions indicates an underlying neoplastic cause. There is evidence that hyperplastic polyps are heterogeneous. Most are innocuous, but subsets may have malignant potential. Risk factors for neoplastic progression include multiple, large, and proximally located polyps. Aberrant methylation resulting in the silencing of cancer genes may be an important underlying mechanism, particularly in pathways progressing to tumors with DNA microsatellite instability. Lesions intermediate between hyperplastic polyp and cancer include admixed polyps and serrated adenomas. Currently, pathologists have different thresholds for diagnosing serrated adenomas, including the distinction from large hyperplastic polyps. Reasons for over looking this pathway in the past may include rapid tumor progression and the fact that proximally located hyperplastic polyps may be flat and not especially numerous. Management of the serrated pathway of colorectal neoplasia may require novel approaches to screening, early detection, and prevention.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11227930     DOI: 10.1007/bf02234287

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  16 in total

1.  Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum?

Authors:  K Baker; Y Zhang; C Jin; J R Jass
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

2.  Ulcerative colitis with inflammatory polyposis in a teenage boy: a case report.

Authors:  Jin-Shan Feng; Ying Ye; Can-Can Guo; Bo-Tao Luo; Xue-Bao Zheng
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

3.  Sonic hedgehog relates to colorectal carcinogenesis.

Authors:  Kozo Yoshikawa; Mitsuo Shimada; Hidenori Miyamoto; Jun Higashijima; Tomohiko Miyatani; Masanori Nishioka; Nobuhiro Kurita; Takashi Iwata; Hisanori Uehara
Journal:  J Gastroenterol       Date:  2009-08-07       Impact factor: 7.527

Review 4.  How does the serrated polyp pathway alter CRC screening and surveillance?

Authors:  Charles J Kahi
Journal:  Dig Dis Sci       Date:  2015-01-04       Impact factor: 3.199

5.  Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site.

Authors:  Andrea N Burnett-Hartman; Michael N Passarelli; Scott V Adams; Melissa P Upton; Lee-Ching Zhu; John D Potter; Polly A Newcomb
Journal:  Am J Epidemiol       Date:  2013-03-03       Impact factor: 4.897

6.  Serrated polyps of the colorectum: is sessile serrated adenoma distinguishable from hyperplastic polyp in a daily practice?

Authors:  Dominique Sandmeier; Walter Seelentag; Hanifa Bouzourene
Journal:  Virchows Arch       Date:  2007-04-21       Impact factor: 4.064

7.  Comparative molecular pathology of sporadic hyperplastic polyps and neoplastic lesions from the same individual.

Authors:  P Zauber; M Sabbath-Solitare; S Marotta; A Zauber; T Bishop
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

8.  Estimated mean sojourn time associated with hemoccult SENSA for detection of proximal and distal colorectal cancer.

Authors:  Wenying Zheng; Carolyn M Rutter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-21       Impact factor: 4.254

9.  Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trial.

Authors:  Adeyinka O Laiyemo; Gwen Murphy; Leah B Sansbury; Zhuoqiao Wang; Paul S Albert; Pamela M Marcus; Robert E Schoen; Amanda J Cross; Arthur Schatzkin; Elaine Lanza
Journal:  Clin Gastroenterol Hepatol       Date:  2008-09-03       Impact factor: 11.382

10.  Serrated colon polyps as precursors to colorectal cancer.

Authors:  Seth Sweetser; Thomas C Smyrk; Frank A Sinicrope
Journal:  Clin Gastroenterol Hepatol       Date:  2012-12-23       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.